Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) to an Investigation of Potential Securities Law Violations Ready to Announce with Confidence?

newsfilecorp.com

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) to an Investigation of Potential Securities Law Violations Ready to Announce with Confidence? New York, New York--(Newsfile Corp. - July 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.

On July 29, 2026, the Federal Trade Commission ("FTC"), the People of the State of California through Los Angeles County Counsel and the Utah Division of Consumer Protection sued Hims & Hers in the Northern District of California. According to the FTC, the action alleges that Hims & Hers fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them." The FTC also alleges that the company has made it difficult for consumers to cancel subscriptions and misled consumers about keeping their health information private. The FTC alleges that Hims shared consumers' health information with Meta, Snap and other third parties.

Following this news, the price of Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this investigation, please contact:

CONTACT:

Pamela A. Mayer

KAPLAN FOX & KILSHEIMER LLP

800 Third Avenue, 38th Floor

New York, New York 10022

(646) 315-9003

pmayer@kaplanfox.com

Laurence D. King

KAPLAN FOX & KILSHEIMER LLP

1999 Harrison Street, Suite 1501

Oakland, California 94612

(415) 772-4704

lking@kaplanfox.com

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/hims-hers-health-inc-class-action-investigation-learn-more-now/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307312

Source: Kaplan Fox & Kilsheimer LLP

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Kaplan Fox & Kilsheimer LLP or all companies in the Legal industry.

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) to an Investigation of Potential Securities Law Violations

2026-07-30 2:30 PM EDT

Kaplan Fox Alerts Investors of EquipmentShare.Com Inc (EQPT) to a Pending Securities Class Action - Deadline is September 21, 2026

2026-07-30 2:15 PM EDT

Kaplan Fox Reminds Photronics, Inc. (PLAB) Investors Seeking Recovery of the Lead Plaintiff Deadline on September 4, 2026

2026-07-30 1:45 PM EDT

May 26, 2026

Disclosure Intelligence Series How disclosure works in modern capital markets When a press release is distributed, most issuer teams treat the process as complete. In reality, this marks the point at which AI systems begin processing, interpreting, and positioning the announcement for the market. To better understand how press releases are processed in modern markets, TMX Newsfile analyzed AI crawler activity across a 72-hour window following press release distribution. The study tracked...

Litigation and Regulation

Legal